Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025
Certara (Nasdaq: CERT) will release third quarter 2025 financial results after market close on November 6, 2025. Management will host a conference call to discuss the results at 5:00 PM ET the same day. Investors must register online to listen and are recommended to register at least one day in advance. A live and archived webcast will be available in the Investors section of Certara's website at https://ir.certara.com/.
Certara (Nasdaq: CERT) pubblicherà i risultati finanziari del terzo trimestre 2025 dopo la chiusura del mercato venerdì 6 novembre 2025. La direzione terrà una conference call per discutere dei risultati alle ore 17:00 ET nello stesso giorno. Gli investitori devono registrarsi online per ascoltare e si raccomanda di registrarsi almeno un giorno prima. Una diretta webcast e una registrazione saranno disponibili nella sezione Investitori del sito di Certara all'indirizzo https://ir.certara.com/.
Certara (Nasdaq: CERT) publicará los resultados financieros del tercer trimestre de 2025 después del cierre del mercado el 6 de noviembre de 2025. La dirección realizará una conferencia telefónica para analizar los resultados a las 5:00 PM ET ese mismo día. Los inversores deben registrarse en línea para escuchar y se recomienda registrarse al menos con un día de antelación. Una transmisión en vivo y una grabación estarán disponibles en la sección Inversionistas del sitio web de Certara en https://ir.certara.com/.
Certara (Nasdaq: CERT)는 2025년 3분기 재무 결과를 2025년 11월 6일 장 마감 후에 발표합니다. 경영진은 같은 날 동부표준시 5:00 PM에 결과를 논의하기 위한 컨퍼런스 콜을 주최합니다. 투자자들은 청취를 위해 온라인으로 등록해야 하며, 가능한 한 하루 전에 등록하는 것이 좋습니다. 라이브 및 아카이브 웹캐스트는 Certara의 웹사이트의 투자자 섹션에서 https://ir.certara.com/로 제공됩니다.
Certara (Nasdaq: CERT) publiera les résultats financiers du troisième trimestre 2025 après la clôture du marché le 6 novembre 2025. La direction organisera une conférence téléphonique pour discuter des résultats le même jour à 17h00 ET. Les investisseurs doivent s’inscrire en ligne pour écouter et il est recommandé de s’inscrire au moins une journée à l’avance. Une conférence web en direct et une version archivée seront disponibles dans la section Investisseurs du site Web de Certara à l’adresse https://ir.certara.com/.
Certara (Nasdaq: CERT) wird die Finanzergebnisse des dritten Quartals 2025 nach Börsenschluss am 6. November 2025 veröffentlichen. Das Management wird am selben Tag eine Telefonkonferenz zur Besprechung der Ergebnisse abhalten um 17:00 Uhr ET. Investoren müssen sich online registrieren, um zuzuhören, und es wird empfohlen, sich mindestens einen Tag im Voraus zu registrieren. Ein Live- und Archiv-Webcast ist im Investor-Bereich der Certara-Website unter https://ir.certara.com/ verfügbar.
Certara (Nasdaq: CERT) ستصدر النتائج المالية للربع الثالث من 2025 بعد اغلاق السوق في 6 نوفمبر 2025. ستجري الإدارة مكالمة مؤتمر لمناقشة النتائج في الساعة 5:00 مساءً بتوقيت شرق الولايات المتحدة في اليوم نفسه. يجب على المستثمرين التسجيل عبر الإنترنت للاستماع ويوصى بالتسجيل قبل يوم واحد على الأقل. سيكون هناك بث مباشر ومقطع أرشيفي متاحان في قسم المستثمرين من موقع Certara على https://ir.certara.com/.
Certara (纳斯达克股票代码:CERT) 将在 2025年11月6日收盘后 公布2025年第三季度的财务业绩。管理层将于同一天 美国东部时间下午5:00 举行电话会议讨论业绩。投资者必须在线注册以收听,建议至少提前一天注册。现场及存档的网络广播将在 Certara 网站的 投资者 部分 https://ir.certara.com/ 提供。
- None.
- None.
RADNOR, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2025 after the market close on Thursday, November 6th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET.
Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance.
A live and archived webcast of the event will be available on the “Investors” section of the Certara website at https://ir.certara.com/.
About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Learn more at certara.com.
Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com
Media Contact:
Alyssa Horowitz
certara@pancomm.com
